SmallCap
CompaniesMapStatistics

(주)쎌바이오텍

Venture Certified
Data Quality: 95/10

Basic Information


Unlisted

Company Name(주)쎌바이오텍
English NameCELL BIOTECH CO ., LTD
Business Reg. No.1368113410
CEO정명준
Address경기 김포시 월곶면 개곡리 134
Industry건강기능식품 제조업
Industry Code10897
EstablishedContact
Phone031-987-6205-7
Websitewww.cellbiotech.com
Regular Employees118persons
Corp. Reg. No.1244110020587

Investment Metrics


Market Cap
-
Op. Margin
11.9%
ROE
11.36%
Debt Ratio
4.15%

Certification Status


Venture Certified

Cert. History
연구개발기업1998-10-23 ~ 2000-06-301998162112-03371998-10-23
연구개발기업2000-07-03 ~ 2002-07-02200016221219271998-10-23
신기술기업(고도기술수반산업)2002-11-15 ~ 2004-11-140216220214050631998-10-23
신기술기업(고도기술수반산업)2004-11-15 ~ 2006-11-140416210325010061998-10-23
연구개발유형2006-11-15 ~ 2008-11-14200604000641998-10-23
연구개발유형2008-11-15 ~ 2010-11-14200804005641998-10-23
연구개발유형2010-11-15 ~ 2012-11-14201004008131998-10-23
연구개발유형2012-11-15 ~ 2014-11-14201204006821998-10-23
연구개발유형2014-11-15 ~ 2016-11-14201404010321998-10-23
연구개발유형2016-11-15 ~ 2018-11-14201604020601998-10-23
연구개발유형2018-11-15 ~ 2020-11-14201804028891998-10-23
연구개발유형2020-11-15 ~ 2022-11-14202004026721998-10-23
연구개발유형2022-11-15 ~ 2025-11-14202212140200401998-10-23
연구개발유형2025-11-15 ~ 2028-11-14202511050200091998-10-23

Financial Statements


3-Year Financial Data

Revenue CAGR -1.4%

Item202420232022
Revenue

462B

509B

475B

Operating Profit

55B

65B

83B

Net Profit

140B

44B

124B

Total Assets

1,282B

1,167B

1,167B

Total Liabilities

51B

41B

54B

Total Equity

1,231B

1,126B

1,113B

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
462B

6.1%

vs. 3-Year Avg.: 492B
Operating Profit
55B

25.5%

vs. 3-Year Avg.: 74B
Op. Margin
11.9%

21.1%

vs. 3-Year Avg.: 15.1%
Debt Ratio
4.1%

2.3%

vs. 3-Year Avg.: 4.2%
ROE
11.4%

50.7%

vs. 3-Year Avg.: 7.5%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
정명준대표이사대표

Employment Status


NPS Subscribers

118persons

CEO정명준
Est. Avg. Annual Salary

4,75110K

(39610K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+1persons

Left (12 mo)

-2persons

Net Change (12 mo)

-1persons

NPS Join Date

1995-06-01

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

69 Patents
51 Registered
8 in 3 Years
A61 의학/수의학/위생 (118)
A23 식품/식료품 (55)
C12 생화학/미생물학 (35)
C07 유기화학 (11)
A01 농업/임업/축산 (9)
Patent TitleApplicantApplication No.Filing DateStatus
근감소증 예방 및 개선 기능성을 가지는 유산균주 락토바실러스 가세리 CBT LGA2주식회사 쎌바이오텍10202401733582024-11-28등록
근감소증 예방 및 개선 기능성을 갖는 유산균 발효 유청 조성물주식회사 쎌바이오텍10202401733572024-11-28거절
혈중 콜레스테롤 저하능을 갖는 비피도박테리움 균주 및 이의 용도주식회사 쎌바이오텍10202401513682024-10-30공개
균주 배양여액을 유효성분으로 하는 작물 방제용 조성물주식회사 쎌바이오텍10202400762822024-06-12공개
여주 유산균 발효물을 포함하는 당뇨병 예방 또는 치료용 약학적 조성물주식회사 쎌바이오텍10202400318522024-03-06공개

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status

Updated: 2026-03-05

Venture

Other Public Data


2 Additional Data Sources

{
  "address": "경기도 김포시 월곶면 애기봉로409번길",
  "brno": "136811****",
  "cappedWarning": false,
  "companyName": "쎌바이오텍(주)",
  "estimatedAvgAnnualSalary": 47511564,
  "estimatedAvgMonthlySalary": 3959297,
  "fetchedAt": "2026-03-05T18:58:27.856Z",
  "industryCode": "152002",
  "industryName": "액상 시유 및 기타 낙농제품 제조업",
  "joinDate": "19950601",
  "last12MonthsHired": 1,
  "last12MonthsLeft": 2,
  "last12MonthsNetChange": -1,
  "leaveDate": null,
  "monthlyPensionAmount": 44383720,
  "monthlyTrend": [
    {
      "lostSubscribers": 2,
      "newSubscribers": 1,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6704927",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 118,
  "turnoverMonths": 1
}

{
  "address": "경기도 김포시",
  "ceo_name": "정명준",
  "certificate": [
    {
      "cert_number": "1998162112-0337",
      "changes": "",
      "disclosure_date": "1998-10-23",
      "first_cert_date": "1998-10-23",
      "no": "1",
      "type": "연구개발기업",
      "valid_period": "1998-10-23 ~ 2000-06-30"
    },
    {
      "cert_number": "20001622121927",
      "changes": "",
      "disclosure_date": "2000-07-03",
      "first_cert_date": "1998-10-23",
      "no": "2",
      "type": "연구개발기업",
      "valid_period": "2000-07-03 ~ 2002-07-02"
    },
    {
      "cert_number": "021622021405063",
      "changes": "",
      "disclosure_date": "2002-11-15",
      "first_cert_date": "1998-10-23",
      "no": "3",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2002-11-15 ~ 2004-11-14"
    },
    {
      "cert_number": "041621032501006",
      "changes": "",
      "disclosure_date": "2004-11-15",
      "first_cert_date": "1998-10-23",
      "no": "4",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2004-11-15 ~ 2006-11-14"
    },
    {
      "cert_number": "20060400064",
      "changes": "",
      "disclosure_date": "2006-11-08",
      "first_cert_date": "1998-10-23",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2006-11-15 ~ 2008-11-14"
    },
    {
      "cert_number": "20080400564",
      "changes": "",
      "disclosure_date": "2008-11-06",
      "first_cert_date": "1998-10-23",
      "no": "6",
      "type": "연구개발유형",
      "valid_period": "2008-11-15 ~ 2010-11-14"
    },
    {
      "cert_number": "20100400813",
      "changes": "",
      "disclosure_date": "2010-10-19",
      "first_cert_date": "1998-10-23",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2010-11-15 ~ 2012-11-14"
    },
    {
      "cert_number": "20120400682",
      "changes": "",
      "disclosure_date": "2012-11-08",
      "first_cert_date": "1998-10-23",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2012-11-15 ~ 2014-11-14"
    },
    {
      "cert_number": "20140401032",
      "changes": "",
      "disclosure_date": "2014-11-04",
      "first_cert_date": "1998-10-23",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2014-11-15 ~ 2016-11-14"
    },
    {
      "cert_number": "20160402060",
      "changes": "",
      "disclosure_date": "2016-12-07",
      "first_cert_date": "1998-10-23",
      "no": "10",
      "type": "연구개발유형",
      "valid_period": "2016-11-15 ~ 2018-11-14"
    },
    {
      "cert_number": "20180402889",
      "changes": "",
      "disclosure_date": "2018-11-28",
      "first_cert_date": "1998-10-23",
      "no": "11",
      "type": "연구개발유형",
      "valid_period": "2018-11-15 ~ 2020-11-14"
    },
    {
      "cert_number": "20200402672",
      "changes": "",
      "disclosure_date": "2020-11-26",
      "first_cert_date": "1998-10-23",
      "no": "12",
      "type": "연구개발유형",
      "valid_period": "2020-11-15 ~ 2022-11-14"
    },
    {
      "cert_number": "20221214020040",
      "changes": "",
      "disclosure_date": "2022-12-14",
      "first_cert_date": "1998-10-23",
      "no": "13",
      "type": "연구개발유형",
      "valid_period": "2022-11-15 ~ 2025-11-14"
    },
    {
      "cert_number": "20251105020009",
      "changes": "",
      "disclosure_date": "2025-11-05",
      "first_cert_date": "1998-10-23",
      "no": "14",
      "type": "연구개발유형",
      "valid_period": "2025-11-15 ~ 2028-11-14"
    }
  ],
  "company_name": "㈜쎌바이오텍",
  "financials": {
    "2022": {
      "capital_stock": 4700000000,
      "cost_of_sales": 12484741000,
      "current_assets": 70314585000,
      "current_liabilities": 5207024000,
      "gross_profit": 34972606000,
      "net_income": 12413416000,
      "net_income_bs": 10733852000,
      "non_current_assets": 46378854000,
      "non_current_liabilities": 154419000,
      "non_operating_expenses": 1680536000,
      "non_operating_income": 5799088000,
      "operating_profit": 8294864000,
      "revenue": 47457347000,
      "sga_expenses": 26677742000,
      "total_assets": 116693439000,
      "total_equity": 111331996000,
      "total_liabilities": 5361443000
    },
    "2023": {
      "capital_stock": 4700000000,
      "cost_of_sales": 14796733000,
      "current_assets": 80851912000,
      "current_liabilities": 3696608000,
      "gross_profit": 36138842000,
      "net_income": 4426327000,
      "net_income_bs": 3961257000,
      "non_current_assets": 35869914000,
      "non_current_liabilities": 440843000,
      "non_operating_expenses": 9213948000,
      "non_operating_income": 7185770000,
      "operating_profit": 6454505000,
      "revenue": 50935575000,
      "sga_expenses": 29684337000,
      "total_assets": 116721827000,
      "total_equity": 112584375000,
      "total_liabilities": 4137451000
    },
    "2024": {
      "capital_stock": 4700000000,
      "cost_of_sales": 13725799000,
      "current_assets": 94310869000,
      "current_liabilities": 4925364000,
      "gross_profit": 32453534000,
      "net_income": 13983673000,
      "net_income_bs": 13500663000,
      "non_current_assets": 33845239000,
      "non_current_liabilities": 180028000,
      "non_operating_expenses": 1218940000,
      "non_operating_income": 9707534000,
      "operating_profit": 5495079000,
      "revenue": 46179333000,
      "sga_expenses": 26958455000,
      "total_assets": 128156108000,
      "total_equity": 123050716000,
      "total_liabilities": 5105392000
    }
  },
  "industry": "건강기능식품 제조업",
  "investment": [],
  "phone": "031-987-****",
  "source": "pg_migration"
}

Data Sources


Data Quality: 95/10 | Primary Source: Venture System | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
Venture System Detail2026-03-05
Collected
SME Status Info2026-03-05
Collected
DART Financial2026-02-26
Collected
Employment Insurance2026-02-25
Collected
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected